In this issue:
- Preclinical tool for enabling patient-centred type 2 diabetes care
- Setmelanotide for acquired hypothalamic obesity
- AI-based OCT for detecting diabetic macular oedema
- Long-term costs of GLP-1 agonists vs. bariatric surgery
- Orforglipron vs. dapagliflozin in inadequately controlled type 2 diabetes
- Continuing GLP-1 agonists into first trimester of pregnancy
- CV and renal outcomes of SGLT-2 inhibitors + GLP-1 agonists in type 2 diabetes
- CGM for weight loss maintenance
- Impact of cold exposure on glucose levels in type 2 diabetes/prediabetes
- Dietary approaches for glycaemic management in type 1 diabetes
Please login below to download this issue (PDF)